March – pre quiz

Episode 6 March (pre quiz)

Please complete the pre-masterclass test to view video.
Which of the following fusion-driven alterations is most responsive to selective ALK inhibitors in NSCLC?(Required)
How have RET inhibitors like selpercatinib changed management of NSCLC with RET fusions?(Required)
Which of the following is a common resistance mechanism seen in ROS1-rearranged NSCLC treated with TKIs?(Required)